project id: TCGA-BLCA; case submitter id: TCGA-DK-AA6Q; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.56; rna integrity number: 8.1; age at index: 61; days to birth: -22314; days to death: 413; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1951; year of death: 2013; age at diagnosis: 22314; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.4; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Posterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Posterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 516; initial weight: 110.0; sample id: daba59a9-8839-4b02-bbf8-4de9c6595a7c; sample submitter id: TCGA-DK-AA6Q-01A; portion id: 187db9d0-d8d0-42d7-874d-a4167f9a5263; portion submitter id: TCGA-DK-AA6Q-01A-11; slide id: ad1a1f6f-78f2-4b75-985e-3fc3af4ecdd1; slide submitter id: TCGA-DK-AA6Q-01A-01-TS1; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 15.0; percent stromal cells: 0.0; percent tumor cells: 85.0; percent tumor nuclei: 70.0; section location: TOP;